FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2091001058> ?p ?o ?g. }

• W2091001058 endingPage "5855" @default.
• W2091001058 startingPage "5850" @default.
• W2091001058 abstract "Persistent infection with the high-risk subset of genitotropic human papillomavirus (HPV) genotypes is a necessary cause of cervical cancer. Given the global burden of cervical cancer, a low-cost, broadly protective vaccine is needed. RG-1 is a cross-neutralizing and protective monoclonal antibody that recognizes residues 17–36 of HPV16 minor capsid protein L2. Because this epitope is highly conserved in divergent HPV types, we determined whether vaccination with HPV16 L2 17–36 peptide is broadly protective. The peptide was administered to BALB/c mice three times at monthly intervals, either alone or in the context of a synthetic lipopeptide vaccine candidate (P25-P2C-HPV) produced by linkage of the HPV peptide with a broadly recognized T helper epitope (P25) and the Toll-like receptor-2 (TLR2) ligand dipalmitoyl- S -glyceryl cysteine (P2C). In contrast to vaccination with the L2 17–36 peptide or P25-P2C alone, a potent L2-specific antibody response was generated to the P25-P2C-HPV lipopeptide when delivered either s.c. or intranasally. Sera from mice vaccinated with the P25-P2C-HPV lipopeptide neutralized not only HPV16 pseudovirions but also other evolutionarily divergent oncogenic genital (HPV18, HPV45) and cutaneous (HPV5, BPV1) types. The L2-specific antibody response depended on MHC class II, CD40, and MyD88 signaling. Additionally, vaccination with the P25-P2C-HPV lipopeptide protected mice from homologous challenge with HPV16 pseudovirions at cutaneous and genital sites and heterologous challenge with HPV45 pseudovirions. If provided in the appropriate context, therefore, HPV16 L2 17–36 might be used in a totally synthetic cross-protective HPV vaccine." @default.
• W2091001058 created "2016-06-24" @default.
• W2091001058 creator A5007840204 @default.
• W2091001058 creator A5010262212 @default.
• W2091001058 creator A5031169359 @default.
• W2091001058 creator A5031584638 @default.
• W2091001058 creator A5059274847 @default.
• W2091001058 creator A5061723842 @default.
• W2091001058 creator A5073996705 @default.
• W2091001058 creator A5075430537 @default.
• W2091001058 creator A5089035026 @default.
• W2091001058 date "2008-04-15" @default.
• W2091001058 modified "2023-09-24" @default.
• W2091001058 title "Protection against heterologous human papillomavirus challenge by a synthetic lipopeptide vaccine containing a broadly cross-neutralizing epitope of L2" @default.
• W2091001058 cites W1486895457 @default.
• W2091001058 cites W1967254492 @default.
• W2091001058 cites W1986850683 @default.
• W2091001058 cites W1987350137 @default.
• W2091001058 cites W1994419043 @default.
• W2091001058 cites W2002199209 @default.
• W2091001058 cites W2007245430 @default.
• W2091001058 cites W2020789898 @default.
• W2091001058 cites W2020830322 @default.
• W2091001058 cites W2069245295 @default.
• W2091001058 cites W2069794080 @default.
• W2091001058 cites W2079442139 @default.
• W2091001058 cites W2087843116 @default.
• W2091001058 cites W2089826905 @default.
• W2091001058 cites W2093480157 @default.
• W2091001058 cites W2095186887 @default.
• W2091001058 cites W2098491904 @default.
• W2091001058 cites W2101196984 @default.
• W2091001058 cites W2102795910 @default.
• W2091001058 cites W2106682089 @default.
• W2091001058 cites W2109148136 @default.
• W2091001058 cites W2112859230 @default.
• W2091001058 cites W2113240161 @default.
• W2091001058 cites W2121819501 @default.
• W2091001058 cites W2125678197 @default.
• W2091001058 cites W2127248987 @default.
• W2091001058 cites W2138364977 @default.
• W2091001058 cites W2157791641 @default.
• W2091001058 cites W2159831861 @default.
• W2091001058 cites W2160808472 @default.
• W2091001058 cites W2417109293 @default.
• W2091001058 cites W4249383371 @default.
• W2091001058 doi "https://doi.org/10.1073/pnas.0800868105" @default.
• W2091001058 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2299222" @default.
• W2091001058 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18413606" @default.
• W2091001058 hasPublicationYear "2008" @default.
• W2091001058 type Work @default.
• W2091001058 sameAs 2091001058 @default.
• W2091001058 citedByCount "140" @default.
• W2091001058 countsByYear W20910010582012 @default.
• W2091001058 countsByYear W20910010582013 @default.
• W2091001058 countsByYear W20910010582014 @default.
• W2091001058 countsByYear W20910010582015 @default.
• W2091001058 countsByYear W20910010582016 @default.
• W2091001058 countsByYear W20910010582017 @default.
• W2091001058 countsByYear W20910010582018 @default.
• W2091001058 countsByYear W20910010582019 @default.
• W2091001058 countsByYear W20910010582020 @default.
• W2091001058 countsByYear W20910010582021 @default.
• W2091001058 countsByYear W20910010582022 @default.
• W2091001058 countsByYear W20910010582023 @default.
• W2091001058 crossrefType "journal-article" @default.
• W2091001058 hasAuthorship W2091001058A5007840204 @default.
• W2091001058 hasAuthorship W2091001058A5010262212 @default.
• W2091001058 hasAuthorship W2091001058A5031169359 @default.
• W2091001058 hasAuthorship W2091001058A5031584638 @default.
• W2091001058 hasAuthorship W2091001058A5059274847 @default.
• W2091001058 hasAuthorship W2091001058A5061723842 @default.
• W2091001058 hasAuthorship W2091001058A5073996705 @default.
• W2091001058 hasAuthorship W2091001058A5075430537 @default.
• W2091001058 hasAuthorship W2091001058A5089035026 @default.
• W2091001058 hasBestOaLocation W20910010582 @default.
• W2091001058 hasConcept C104317684 @default.
• W2091001058 hasConcept C151730666 @default.
• W2091001058 hasConcept C159047783 @default.
• W2091001058 hasConcept C159654299 @default.
• W2091001058 hasConcept C195616568 @default.
• W2091001058 hasConcept C203014093 @default.
• W2091001058 hasConcept C22070199 @default.
• W2091001058 hasConcept C2777425210 @default.
• W2091001058 hasConcept C2779343474 @default.
• W2091001058 hasConcept C2780115692 @default.
• W2091001058 hasConcept C523546767 @default.
• W2091001058 hasConcept C542903549 @default.
• W2091001058 hasConcept C54355233 @default.
• W2091001058 hasConcept C86803240 @default.
• W2091001058 hasConceptScore W2091001058C104317684 @default.
• W2091001058 hasConceptScore W2091001058C151730666 @default.
• W2091001058 hasConceptScore W2091001058C159047783 @default.
• W2091001058 hasConceptScore W2091001058C159654299 @default.
• W2091001058 hasConceptScore W2091001058C195616568 @default.
• W2091001058 hasConceptScore W2091001058C203014093 @default.
• W2091001058 hasConceptScore W2091001058C22070199 @default.
• W2091001058 hasConceptScore W2091001058C2777425210 @default.

• next